(Q36962703)

17 August 2017

1 reference

title

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour? (English)

1 reference

17 August 2017

1 reference

Harro J

1

1 reference

PubMed ID

1792008

17 August 2017

Vasar E

series ordinal

2

1 reference

17 August 2017

1 January 1991

1 reference

Neuroscience & Biobehavioral Reviews

17 August 2017

1 reference

17 August 2017

15

1 reference

17 August 2017

473-477

1 reference

17 August 2017

4

1 reference

Cholecystokinin-4 and panic.

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

The role of CCK caerulein, and CCK antagonists in nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Modulation of mesolimbic dopaminergic behaviors by cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Neuropeptide modulation of social and exploratory behaviors in laboratory rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventricles

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Classification and function of CCK receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Cholecystokinin and gastrin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Benzodiazepines, putative anxiolytics and animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Specificity of nucleus accumbens to activities related to cholecystokinins in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Influence of dopamine on limbic inputs to the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

The relation between fear induced by novel stimulation and exploratory drive

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Two brain cholecystokinin receptors: implications for behavioral actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Cholecystokinin and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Evidence for a role for dopamine in the diazepam locomotor stimulating effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

Neuropharmacological profile of cholecystokinin-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2805%2980134-4

7 January 2021

10.1016/S0149-7634(05)80134-4

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

1792008